This page looks plain and unstyled because you're using a non-standard compliant browser. To see it in its best form, please upgrade to a browser that supports web standards. It's free and painless.

Website Home | Blog Home | Contact Us | Albums | Admin

« | »

Examining the 'Black Box' Process

HenryHanflik | 20 August, 2008 11:15

The Food and Drug Administration has recently considered two drugs for its strictest warning. Cipro and the similar antibiotics and a class of epilepsy drugs were both under consideration for the so-called black box warning. However, only one received restricted labeling. The Los Angeles Times examines the process behind tougher warnings. Karen Ravn, LA Times 08/18/2008

Read Article: LA Times


Valid XHTML 1.0 Strict and CSS.
Powered by pLog
Design by Book of Styles